Our study showed the absence of IgA in serum and breast milk within 20 days in 41 women after the second vaccine dose, possibly dependent on a rapid decrease in the IgA antibody response as observed by other previous studies in COVID-19 convalescent individuals and vaccinated subjects [7,8]. The gene discussed is CD79A; the disease is COVID-19.